Man Group PLC Tenaya Therapeutics, Inc. Transaction History

Man Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.73 - $3.39 $4,527 - $8,871	-2,617 Reduced 6.36%	38,540 $124,000
Q3 2023 Nov 14, 2023	BUY	$2.55 - $5.65 $104,950 - $232,537	41,157 New	41,157 $104,000
Q1 2023 May 15, 2023	BUY	$1.92 - $3.59 $79,516 - $148,679	41,415 New	41,415 $118,000

56.3M

900

400

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $69.1M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.